Surgalign Holdings Inc
XBER:RT2
Operating Margin
Surgalign Holdings Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | Company | Market Cap |
Operating Margin |
||
---|---|---|---|---|---|
US |
S
|
Surgalign Holdings Inc
F:RT2
|
20.1m EUR |
-87%
|
|
CH |
![]() |
Alcon AG
SIX:ALC
|
34.7B CHF |
14%
|
|
JP |
![]() |
Hoya Corp
TSE:7741
|
6.3T JPY |
29%
|
|
DK |
![]() |
Coloplast A/S
CSE:COLO B
|
136.6B DKK |
27%
|
|
US |
![]() |
Align Technology Inc
NASDAQ:ALGN
|
13.9B USD |
16%
|
|
CH |
![]() |
Ypsomed Holding AG
SIX:YPSN
|
5.8B CHF |
15%
|
|
UK |
![]() |
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP |
15%
|
|
CN |
![]() |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.9B CNY |
43%
|
|
KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.9T KRW |
-149%
|
|
CA |
![]() |
Bausch + Lomb Corp
NYSE:BLCO
|
4.9B USD |
3%
|
|
US |
![]() |
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.9B USD |
12%
|
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Surgalign Holdings Inc's most recent financial statements, the company has Operating Margin of -87.3%.